Brain Cancer Diagnostics Market Insights & Forecast 2034
Coverage: Brain Cancer Diagnostics Market covers analysis By Diagnostic Type (Imaging Test, Lumbar Puncture, Biopsy, Molecular Testing, Platform and Services, Cerebral Arteriogram, Neurological & Hearing Tests/Neurocognitive Assessments, Electroencephalography ); Cancer Type (Acoustic Neuroma, Astrocytomas, Craniopharyngiomas, Ganglioneuromas, Glioblastoma Multiforme, Meningiomas, Ependymomas, Oligodendroglioma, Low-Grade Tumors ); End User (Hospitals, Specialty Clinics, Diagnostic Centers & Research Institutes, Ambulatory Surgical Centers (ASCs)); Tumor Size, 0.2 cm3 to 100 cm3, 101 cm3 to 200 cm3, Above 200 cm3); and Geography
- Report Date : Mar 2026
- Report Code : TIPRE00024461
- Category : Life Sciences
- Status : Upcoming
- Available Report Formats :
- No. of Pages : 150
The Brain Cancer Diagnostics Market size is expected to reach US$ 35.37 Billion by 2034 from US$ 3.53 Billion in 2025. The market is anticipated to register a CAGR of 29.17% during 2026–2034.
Brain Cancer Diagnostics Market AnalysisThe brain cancer diagnostics market forecast indicates extraordinary growth, driven by the revolutionary integration of advanced technology into neuro-oncology workflows. The acceleration is largely attributed to AI-enabled neuroimaging, which provides quantitative analysis for small-lesion detectability and standardized reporting across various sites. This is supplemented by the rapid adoption of precision molecular profiling, including DNA methylation analysis, Next-Generation Sequencing (NGS) panels, and the emerging field of liquid biopsy from Cerebrospinal Fluid (CSF) and plasma. These cutting-edge tools, exemplified by products like GE HealthCare’s Q.Clear PET quantitation and Philips’ NeuroQuant® integration, allow for highly accurate, reproducible diagnosis and facilitate therapy selection aligned with the latest WHO 2021 Central Nervous System (CNS) classification standards. The market expansion is characterized by the imperative to integrate this complex imaging and genomic data, allowing hospitals and speciality centres to make faster, more confident diagnostic decisions.
Brain Cancer Diagnostics Market OverviewBrain cancer diagnostics comprises a critical suite of sophisticated modalities, including high-field magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET/CT) with perfusion and spectroscopy capabilities, alongside tissue biopsy and less-invasive methods like lumbar puncture. Beyond imaging, the core of the market is shifting towards complex molecular testing, including NGS, methylation profiling, and molecular status assessment (e.g., IDH, MGMT), which are essential for tumor classification and prognosis. Solutions span the entire patient journey, from initial noninvasive screening and precise surgical planning to treatment selection and post-therapy surveillance for both primary tumors (like glioblastoma and meningioma) and metastatic CNS disease. The market's competitive dynamic is defined by rapid AI tool adoption in image interpretation, increasing demand for quantitative, longitudinal analysis, and the expanding clinical validation and reimbursement for multi-analyte liquid biopsy assays.
Strategic InsightsBrain Cancer Diagnostics Market Drivers and OpportunitiesMarket Drivers:
- Rising Incidence of CNS Tumors: The growing global burden of primary and secondary brain cancers across both adult and pediatric populations drives an urgent demand for improved diagnostic sensitivity and specificity, particularly for detecting smaller lesions and providing differential diagnosis early in the disease course.
- AI-Enabled, Quantitative Neuroimaging Standardizing Diagnosis: The integration of deep-learning algorithms into advanced MRI and PET/CT systems (e.g., Siemens Healthineers' AI-Rad Companion) is dramatically improving the quality and reproducibility of imaging. These AI tools enhance small-lesion detectability, provide standardized volumetric analysis, and automate reporting, which is crucial for multidisciplinary team consensus.
- Molecular/Epigenetic Diagnostics Embedded in Clinical Guidelines: The mandatory requirement for molecular data, such as DNA methylation status and specific genetic mutations (IDH, TERT), to classify CNS tumors according to the WHO 2021 guidelines, has firmly established advanced molecular testing as a non-negotiable component of the diagnostic workflow, directly driving the market.
Market Opportunities:
- Clinical Validation and Reimbursement Expansion for Liquid Biopsy: Achieving broader clinical validation and obtaining national reimbursement coverage for highly accurate CSF multi-analyte assays and plasma cfDNA tests represents a huge opportunity to transition from tissue-only diagnostics to routine noninvasive screening and post-treatment recurrence monitoring.
- Companion Diagnostics and Multi-Omics Panels for Precision Therapy: Developing specialized companion diagnostics that predict patient response to targeted therapies (e.g., MGMT promoter methylation testing for temozolomide) and creating multi-omics panels that link tumor genomics, epigenomics, and proteomics will enable hyper-personalized treatment stratification.
- Workflow Automation to Address Specialist Shortages: Implementing AI-driven solutions that automate segmentation, quantitative analysis, and reporting can alleviate the workload on neuroradiologists and pathologists, ensuring that advanced quantitative neuroimaging practices are standardized and scalable across regions facing specialist shortages.
The brain cancer diagnostics market share is analyzed across various segments to provide a clearer understanding of its structure, growth potential, and emerging technological trends. Below is a detailed segmentation approach used in most industry reports:
By Diagnostic Type:
- Imaging Test
- Lumbar Puncture
- Biopsy
- Molecular Testing
- Platform and Services
- Cerebral Arteriogram
- Neurological & Hearing Tests/Neurocognitive Assessments
- Electroencephalography
By Cancer Type:
- Acoustic Neuroma
- Astrocytomas
- Craniopharyngiomas
- Ganglioneuromas
- Glioblastoma Multiforme
- Meningiomas
- Ependymomas
- Oligodendroglioma
- Low-Grade Tumors
By End User:
- Hospitals
- Specialty Clinics
- Diagnostic Centers & Research Institutes
- Ambulatory Surgical Centers (ASCs)
By Tumor Size
- 0.2 cm3 to 100 cm3
- 101 cm3 to 200 cm3
- Above 200 cm3
By Geography:
- North America
- Europe
- Asia Pacific
- South & Central America
- Middle East & Africa
The brain cancer diagnostics market exhibits distinct growth and technology adoption patterns across global regions, influenced by healthcare spending, regulatory alignment with precision medicine, and the existing infrastructure for advanced diagnostics. Below is a summary of market share and trends by region:
North America
- Market Share: Holds the largest market share globally due to mature regulatory pathways, high healthcare expenditure, and a strong culture of adopting cutting-edge technologies.
- Key Drivers: Favorable reimbursement environment for advanced genomic and epigenetic testing.
- Trends: Strong shift towards multi-omics data integration and the development of vendor-neutral platforms that connect imaging, pathology, and genomics data.
Europe
- Market Share: Significant market share, driven by strong academic research in neuro-oncology and increasing national healthcare system commitment to precision medicine.
- Key Drivers: High demand for harmonizing diagnostic standards across different countries.
- Trends: Focus on implementing standardized quantitative neuroimaging protocols and expanding access to molecular testing through centralized reference laboratories.
Asia Pacific
- Market Share: Fastest-growing region, driven by massive investments in oncology infrastructure and expanding patient populations.
- Key Drivers: Increasing adoption of NGS panels to address the rising brain cancer burden.
- Trends: High demand for cost-effective, scalable diagnostic solutions; growing interest in local clinical validation of advanced liquid biopsy techniques.
South and Central America
- Market Share: Emerging market with developing digital health and specialized diagnostics infrastructure.
- Key Drivers: Expansion of private oncology clinics leading the adoption of scalable, newer technologies.
- Trends: Cloud-based imaging reading and tele-radiology solutions are gaining traction to overcome geographic barriers and specialist shortages.
Middle East and Africa
- Market Share: Developing market with strong growth potential fueled by national healthcare modernization initiatives.
- Key Drivers: Increasing access to advanced imaging equipment in major cities.
- Trends: Focus on establishing foundational diagnostic capabilities and gradually integrating AI tools to maximize the efficiency of newly acquired imaging equipment.
High Market Density and Competition
Competition in the brain cancer diagnostics market is intense and fragmented, spanning two distinct technology areas: advanced imaging and precision molecular diagnostics. Major vendors such as Siemens Healthineers AG, GE HealthCare, and Koninklijke Philips N.V. dominate the imaging space, while companies like THERMO FISHER SCIENTIFIC INC and MDxHealth lead the molecular and genomic segments. Regional and niche molecular players like Biocept, Inc. also contribute significantly to the competitive landscape.
This environment pushes vendors to differentiate through:
- AI Integration: Embedding AI algorithms directly into imaging hardware and software to automate quantitative measurements (e.g., tumor volume) and standardize reporting.
- Multi-Modal Platforms: Offering solutions that can seamlessly combine data from imaging, pathology, and genomics to create a single, comprehensive patient profile.
- Minimally Invasive Diagnostics: Investing heavily in validating and commercializing noninvasive liquid biopsy assays (CSF and plasma) to reduce patient risk and improve monitoring frequency.
- Alignment with Guidelines: Ensuring that molecular diagnostic offerings are perfectly aligned with the latest clinical classification standards, such as the WHO 2021 CNS criteria.
- THERMO FISHER SCIENTIFIC INC
- Siemens Healthineers AG
- GE HealthCare
- Koninklijke Philips N.V.
- MDxHealth
- Biocept, Inc.
- Canon Medical Systems
- Hitachi, Ltd
- NantOmics
Disclaimer: The companies listed above are not ranked in any particular order.
Brain Cancer Diagnostics Market News and Recent Developments- Thermo Fisher Scientific Inc. is advancing brain tumor biomarker testing through its Oncomine™ NGS solutions, including the Oncomine Dx Express Test powered by the Ion Torrent Genexus Dx system. The company also supports spatial omics in neuroscience, enabling dual ISH–IHC brain mapping, which preserves deep molecular context to enhance brain cancer diagnostics research.
- Siemens Healthineers AG continues to strengthen neuroradiology and neuro-oncology capabilities through its Neurology Biomarkers and Assays, including blood-based neurofilament light chain testing. Siemens’ innovations in imaging, such as MAGNETOM and Biograph mMR systems, Deep Resolve AI reconstruction, and the photon-counting CT NAEOTOM Alpha, offer improved tumor imaging precision and diagnostic reliability.
The "Brain Cancer Diagnostics Market Size and Forecast (2021–2034)" report provides a detailed analysis of the market covering below areas:
- Brain Cancer Diagnostics Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Brain Cancer Diagnostics Market trends, as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST and SWOT analysis
- Brain Cancer Diagnostics Market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments in the Brain Cancer Diagnostics Market
- Detailed company profiles
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Diagnostic Type; Cancer Typ; End User ; and Tumor Size
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Major opportunities in the Brain Cancer Diagnostics Market include liquid biopsy expansion, companion diagnostics development, and AI-driven workflow automation.
North America leads the Brain Cancer Diagnostics Market due to strong adoption of precision diagnostics and favorable reimbursement frameworks.
AI-powered neuroimaging, NGS, DNA methylation profiling, and emerging liquid biopsy tools are the leading technologies influencing the Brain Cancer Diagnostics Market.
Growth in the Brain Cancer Diagnostics Market is driven by rising brain cancer incidence, AI-enabled imaging standardization, and expanding molecular and epigenetic diagnostics.
The Brain Cancer Diagnostics Market is projected to reach US$35.37 billion by 2034, supported by rapid advances in AI imaging and molecular testing.
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For